4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-032273
Senior Vice President and CFO sold 10,856 shares at an average $7.84 ($85,090)
- Senior Vice President and CFO acquired 10,856 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-02 | Exercise or conversion : show line 1 in the form | +7,356 | $3.22 | $23,686 | 144,739 | D |
| 2018-11-02 | Sale : show line 2 in the form | −7,356 | $7.78 | $57,230 | 137,383 | D |
| 2018-11-02 | Exercise or conversion : show line 3 in the form | +3,500 | $3.78 | $13,230 | 140,883 | D |
| 2018-11-02 | Sale : show line 4 in the form | −3,500 | $7.96 | $27,860 | 137,383 | D |
| Open-market sales · 10,856 sh · avg $7.84 · $85,090 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-11-02 | Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) | −7,356 | 115,571 | D |
| 2018-11-02 | Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) | −3,500 | 45,805 | D |
Loading xslF345X03/form4.xml…